α Enolase Inhibitors

Common α Enolase Inhibitors include, but are not limited to NSC 66811 CAS 6964-62-1, Sodium Citrate, Dihydrate CAS 6132-04-3, trans-Cinnamic acid CAS 140-10-3, Sodium phosphonoformate tribasic hexahydrate CAS 34156-56-4 and Triethyl Phosphonoacetate CAS 867-13-0.

α Enolase inhibitors belong to a chemical class of compounds designed to selectively target and inhibit the function of α enolase, an enzyme that plays a crucial role in glycolysis, the central metabolic pathway responsible for converting glucose into energy. α enolase catalyzes the conversion of 2-phosphoglycerate (2-PG) to phosphoenolpyruvate (PEP), a key step in glycolysis that generates high-energy phosphate bonds essential for cellular energy production. Additionally, α enolase has been found to have non-glycolytic functions, such as being involved in cell adhesion, plasminogen binding, and transcriptional regulation.

Inhibiting α enolase aims to interfere with its enzymatic activity and disrupt glycolysis, impacting the cellular energy production and various downstream metabolic processes. Additionally, targeting α enolase could have implications for its non-glycolytic functions, influencing processes such as cell adhesion and signaling pathways. By studying the effects of α enolase inhibitors, researchers can gain insights into the multifaceted roles of α enolase in cellular physiology and metabolism, uncovering its contributions to both energy production and other cellular processes. This class of inhibitors provides a valuable tool for investigating the intricate interactions of α enolase in different cellular contexts and expanding our understanding of its diverse functions.